New Drugs in Development for the Treatment of Diabetes
Diabetes Spectrum Volume 22, Number 2, 2009
In Brief
A variety of new agents are in development for the treatment of type 1 or type 2 diabetes. In addition to new dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 analogs, thiazolidinediones, glinides, and new insulin formulations, there are also unique peroxisome proliferator–activated receptor agonists, selective sodium glucose cotransporter 2 inhibitors, and several other unique agents now in development.